πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 252 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10233235

Modulating the alternative complement pathway

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10232035

Conditionally replication deficient herpes virus and use thereof in vaccines

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10233222

Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10221222

Dermaseptin-type and piscidin-type antimicrobial peptides

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10221226

LEDGF peptides and formulations thereof for treatment of degenerative disorders

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10214487

Indole derivatives and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10202397

Anti-cancer compounds targeting Ral GTPases and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10160962

Purification of cystathionine beta-synthase

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10155020

Compositions and methods for treating hepatitis B

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10130604

Composition and method for treating neurodegenerative disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117915

Modulation of yeast-based immunotherapy products and responses

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10111861

Treatment of breast cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10080376

Method for enhancing postprocessing content of beneficial compounds in beverages naturally

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10076520

Use of tyrosine kinase inhibitor in cancer treatment

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10052393

Multifunctional nanomaterials for the treatment of cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10046036

Chemically modified cystathionine Ξ²-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9994901

Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary dis

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9980634

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9949928

Biodegradable copolymers, systems including the copolymers, and methods of forming and usi

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9949484

Antimicrobial polyurethane materials and methods of forming and using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9950044

Treatment of pulmonary vascular remodeling with neprilysin

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9938353

Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9895420

IL-1beta propeptide and IL-1Ra chimera and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884096

Compositions and methods related to graft versus host disease and treatments thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted